Retroscreen Virology Group PLC New state of the art biomedical facility in UK
March 19 2014 - 3:03AM
RNS Non-Regulatory
TIDMRVG
Retroscreen Virology Group PLC
19 March 2014
For immediate release 07.00: 19 March 2014
RETROSCREEN VIROLOGY GROUP PLC
("Retroscreen" or the "Company")
NEW STATE OF THE ART BIOMEDICAL FACILITY IN UK
Retroscreen Virology Group plc (AIM: RVG), the viral challenge
and "virometrics" specialist, is pleased to announce that it has
signed a long term lease on a facility at the Chesterford Research
Park in the UK with the plan to create a state of the art
biomedical facility. This new bespoke facility will allow the
further development and commercial exploitation of the Company's
viral challenge technology platform.
Located at Little Chesterford in North Essex, the 42,000 square
foot facility will house a quarantine unit, containing 40 ensuite
isolation beds, together with a separate suite of laboratories for
the Company's bioanalytical work. The facility, which is targeted
to be fully operational in early 2015, will dramatically improve
and broaden the Company's operational capability. In particular,
this planned expansion will allow the Company both to conduct
clinical studies for its clients and to leverage its new viral
challenge models for commercial and research purposes.
Kym Denny, Chief Executive Officer, commented, "Retroscreen is
actively broadening its capabilities and this new bespoke facility
at Chesterford will allow us to undertake bedside to bench
biomedical research all on one site. This exciting development
follows the successful inoculation of our 1,500(th) volunteer which
was achieved in just over a year since reaching the landmark of our
1,000(th) volunteer inoculation on 10 December 2012. This is a
testament to the industry's adoption of our viral challenge models
and our client delivery."
For further information please contact:
Retroscreen Virology Group plc +44 207 756 1300
Kym Denny (CEO)
Graham Yeatman (FD)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAGRGDXXGBBGSC
Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024